# Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.

> PubMed lists PMID 8063245 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1994-08 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8063245-leuprolide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8063245-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8063245-leuprolide-v1.json
- Content SHA-256: `3d6e4842b762e5b929a42bca4bf91fbd898e8318897de026198a9bc847ac5fb5`

## Claims and source pins

### Headline

Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma. ([`pubmed-observation-pmid-8063245-2013-11-21-106e08f55429`](#source-pubmed-observation-pmid-8063245-2013-11-21-106e08f55429))

### Summary

PubMed lists PMID 8063245 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1994-08 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8063245-2013-11-21-106e08f55429`](#source-pubmed-observation-pmid-8063245-2013-11-21-106e08f55429))

### Paragraph 1

PubMed lists PMID 8063245 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1994-08 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8063245-2013-11-21-106e08f55429`](#source-pubmed-observation-pmid-8063245-2013-11-21-106e08f55429))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8063245-2013-11-21-106e08f55429`](#source-pubmed-observation-pmid-8063245-2013-11-21-106e08f55429))

## Sources

<a id="source-pubmed-observation-pmid-8063245-2013-11-21-106e08f55429"></a>
- **Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma. · retained source version 1:2013-11-21:current:106e08f55429b6e17db7a37aa400329bf9ea2a63b7acbe9451338a7ee6a76021** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8063245/) (`pubmed-observation-pmid-8063245-2013-11-21-106e08f55429`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8063245-leuprolide-v1.json SHA-256: 3d6e4842b762e5b929a42bca4bf91fbd898e8318897de026198a9bc847ac5fb5.